Successful medical therapy of left main thrombosis: Value of serial coronary angiography

Journal of Invasive Cardiology

Volumn 13, Issue 9, 2001, Pages 644-646

  Deliargyris, Efthymios N ^a,b   Dehmer, Gregory J ^a   Willis IV, Park W ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndromes; Coronary angiography; Coronary thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY THROMBOSIS; FEMALE; HUMAN; RADIOGRAPHY;

AGED; ANTICOAGULANTS; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; HEPARIN; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 0035462355     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855-860.
2. Deliargyris EN, Raymond RJ, Theoharides TC, et al. Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am J Cardiol 2000;86:913-918.
3. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. Lancet 1996;348:771-775.
4. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the the TIMI IIIB trial. Circulation 1994;89:1545-1556.
5. Oler A, Whooley M, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. JAMA 1996;276:811-815.
6. Cohen M, Ferguson III JJ, Harrington RA. Trials of glycoprotein IIb/IIIa inhibitors in non-ST segment elevation acute coronary syndromes: Applicability to the practice of medicine in the United States. Clin Cardiol 1999;22(Suppl VI):2-12.
7. O'Shea JC, Bahit C, Tolleson TR, et al. Highlights from the American Heart Association Annual Scientific Sessions 2000: November 12-15, 2000. Am Heart J 2001;141:306-318.
8. James S, Lindahl B, Venge P, et al. No beneficial effect of 24-48 hours abciximab infusion in aspirin and heparin treated acute coronary syndrome patients with elevated troponin without early revascularization procedures: A Gusto IV substudy. J Am Coll Cardiol 2001;37(Suppl A):326A.
9. Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with conservative management strategy. Veterans Affairs Non-Q-wave Infarction Strategies InHospital (VANQWISH) Trial Investigators. N Engl J Med 1998;338:1785-1792.
10. Fragmin and Fast Revascularization during Instability in Coronary artery disease (FRISC-II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicenter study. Lancet 1999;354:708-715.
11. Scull GS, Martin JS, Weaver D, et al. Early angiography versus conservative treatment in patients with non-ST elevation acute myocardial infarction. J Am Coll Cardiol 2000;35:895-902.